Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares").
- Disclosed ownership: 3.9%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 3.9% ownership in Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares") on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.9% | 369,733 | 0 | 369,733 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.9% | 369,733 | 0 | 369,733 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.9% | 369,733 | 0 | 369,733 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0% | 0 | 0 | 0 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities Group LP | 0% | 0 | 0 | 0 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities GP LLC | 0% | 0 | 0 | 0 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Kenneth Griffin | 3.9% | 369,733 | 0 | 369,733 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |